DrugRepV_2977 | Apigenin | NA | NA | Chikungunya virus | CHIKV replicon | NA | EGFP assay | Decrease (50 %) | Experimental | 22205980 |
DrugRepV_2978 | Chrysin | Plant extract | NA | Chikungunya virus | CHIKV replicon | NA | EGFP assay | Decrease (50 %) | Experimental | 22205980 |
DrugRepV_2979 | Naringenin | NA | NA | Chikungunya virus | CHIKV replicon | NA | EGFP assay | Decrease (50 %) | Experimental | 22205980 |
DrugRepV_2980 | Silybin | NA | NA | Chikungunya virus | CHIKV replicon | NA | EGFP assay | Decrease (50 %) | Experimental, Investigational | 22205980 |
DrugRepV_2981 | Prothipendyl | Nervous System | Dementia | Depression | Schizophrenia | Anxiety Disorders | Psychosomatic Disorders | Chikungunya virus | CHIKV replicon | NA | EGFP assay | Decrease (50 %) | Investigational | 22205980 |
DrugRepV_2982 | Ribavirin | Antiinfectives For Systemic Use | Hepatitis C virus | Chikungunya virus | CHIKV replicon | NA | EGFP assay | Decrease (50 %) | Approved | 22205980 |
DrugRepV_2983 | Mycophenolic Acid | Antineoplastic and Immunomodulating Agents | Organ rejection (immunosuppressants) | Chikungunya virus | CHIKV replicon | NA | EGFP assay | Decrease (50 %) | Approved | 22205980 |
DrugRepV_2984 | 6-Azauridine | NA | Cancer | Chikungunya virus | CHIKV replicon | NA | EGFP assay | Decrease (50 %) | NA | 22205980 |
DrugRepV_2985 | 3-NH2-3-deoxyadenosine | NA | NA | Chikungunya virus | CHIKV replicon | NA | EGFP assay | Decrease (50 %) | NA | 22205980 |
DrugRepV_7103 | Chebulagic Acid | NA | Immunosuppressive and hepatoprotective | Measles virus | IC323 | | EGFP assay | Decrease (50 %) | NA | 23924316 |
DrugRepV_7104 | Punicalagin | Plant pigment | NA | Measles virus | IC323 | | EGFP assay | Decrease (50 %) | NA | 23924316 |
DrugRepV_7105 | Chebulagic Acid | NA | Immunosuppressive and hepatoprotective | Measles virus | IC323 | | EGFP assay | Decrease (80 %) | NA | 23924316 |
DrugRepV_7106 | Punicalagin | Plant pigment | NA | Measles virus | IC323 | | EGFP assay | Decrease (80 %) | NA | 23924316 |